Ribonucleotide reductase inhibitors: New strategies for cancer chemotherapy

被引:97
作者
Nocentini, G
机构
[1] Dept. Clin. Med., Pathol. Pharmacol., Sezione Farmacologia, University of Perugia, 06100 Perugia, V. del Giochetto
[2] Dept. Clin. Med., Pathol. Pharmacol., University of Perugia, Perugia
关键词
D O I
10.1016/1040-8428(95)00187-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:89 / 126
页数:38
相关论文
共 337 条
[1]   EFFICACY AND SAFETY PROFILE OF GEMCITABINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY [J].
ABRATT, RP ;
BEZWODA, WR ;
FALKSON, G ;
GOEDHALS, L ;
HACKING, D ;
RUGG, TA .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) :1535-1540
[2]  
AKERBLOM L, 1985, J BIOL CHEM, V260, P9197
[3]  
ALBAIN KS, 1992, SEMIN ONCOL, V19, P102
[4]   SYNERGISTIC AND COORDINATE EXPRESSION OF THE GENES ENCODING RIBONUCLEOTIDE REDUCTASE SUBUNITS IN SWISS 3T3 CELLS - EFFECT OF MULTIPLE SIGNAL-TRANSDUCTION PATHWAYS [J].
ALBERT, DA ;
ROZENGURT, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1597-1601
[5]   DNA-REPAIR MUTANTS DEFINING G2 CHECKPOINT PATHWAYS IN SCHIZOSACCHAROMYCES-POMBE [J].
ALKHODAIRY, F ;
CARR, AM .
EMBO JOURNAL, 1992, 11 (04) :1343-1350
[6]  
AMARA FM, 1994, J BIOL CHEM, V269, P6709
[7]   SINGLE-AGENT ACTIVITY OF WEEKLY GEMCITABINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY [J].
ANDERSON, H ;
LUND, B ;
BACH, F ;
THATCHER, N ;
WALLING, J ;
HANSEN, HH .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1821-1826
[8]   2-AMINOPURINE OVERRIDES MULTIPLE CELL-CYCLE CHECKPOINTS IN BHK CELLS [J].
ANDREASSEN, PR ;
MARGOLIS, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2272-2276
[9]  
ANTHOLINE W, 1977, MOL PHARMACOL, V13, P89
[10]   NSTAR-NSTAR-SSTAR TRIDENTATE LIGAND SYSTEM AS POTENTIAL ANTI-TUMOR AGENTS [J].
ANTONINI, I ;
CLAUDI, F ;
CRISTALLI, G ;
FRANCHETTI, P ;
GRIFANTINI, M ;
MARTELLI, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (10) :1181-1184